Cutting edge issues in the Churg-Strauss syndrome

Clinical Reviews in Allergy and Immunology

Volumn 44, Issue 1, 2013, Pages 39-50

  Szczeklik, Wojciech ^a   Jakieła, Bogdan ^a   Adamek, Dariusz ^a   Musiał, Jacek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Churg Strauss syndrome; Eosinophils; Pathogenesis; Vasculitis

Indexed keywords

AZATHIOPRINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; METHOTREXATE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTICLE; ASTHMA; CARDIOVASCULAR SYSTEM; CHURG STRAUSS SYNDROME; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; INTESTINE ISCHEMIA; INTESTINE NECROSIS; LIVEDO RETICULARIS; NEUROLOGIC DISEASE; PETECHIA; PHENOTYPE; PROGNOSIS; RESPIRATORY SYSTEM; SUBCUTANEOUS NODULE; TH2 CELL; URTICARIA;

CARDIOVASCULAR DISEASES; CHURG-STRAUSS SYNDROME; HUMANS; NERVOUS SYSTEM DISEASES; PHENOTYPE; PROGNOSIS; RESPIRATORY TRACT DISEASES; TREATMENT OUTCOME;

EID: 84872679616     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-011-8266-y     Document Type: Article

References (108)

1. Noth I, Strek ME, Leff AR (2003) Churg-Strauss syndrome. Lancet 361(9357):587-594 (Pubitemid 36207480)
2. Pagnoux C, Guillevin L (2010) Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 22(1):21-28
3. Weller PF, Plaut M, Taggart V, Trontell A (2001) The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. J Allergy Clin Immunol 108(2):175-183 (Pubitemid 32735397)
4. Rackemann FM (1939) Periarteritis nodosa and asthma. Trans Assoc Am Physicians 54:112-118
5. Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27(2):277-301
6. Watts RA, Lane S, Scott DG (2005) What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 19(2):191-207
7. Harrold LR, Andrade SE, Go AS et al (2005) Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. J Rheumatol 32(6):1076-1080 (Pubitemid 40828082)
8. Loughlin JE, Cole JA, Rothman KJ, Johnson ES (2002) Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients. Ann Allergy Asthma Immunol 88(3):319-325 (Pubitemid 34245978)
9. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P (1999) Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Med (Baltimore) 78(1):26-37 (Pubitemid 29065978)
10. Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37(2):187-192 (Pubitemid 24065492)
11. Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Med (Baltimore) 63(2):65-81 (Pubitemid 14166819)
12. Guillevin L, Lhote F, Gayraud M et al (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Med (Baltimore) 75(1):17-28 (Pubitemid 26041085)
13. Reid AJ, Harrison BD, Watts RA, Watkin SW, McCann BG, Scott DG (1998) Churg-Strauss syndrome in a district hospital. QJM 91(3):219-229 (Pubitemid 28115855)
14. Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094-1100 (Pubitemid 20273293)
15. Rao JK, Allen NB, Pincus T (1998) Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 129(5):345-352 (Pubitemid 28402788)
16. Churg A (2001) Recent advances in the diagnosis of Churg-Strauss syndrome. Mod Pathol 14(12):1284-1293 (Pubitemid 33151172)
17. Beasley R, Bibby S, Weatherall M (2008) Leukotriene receptor antagonist therapy and Churg-Strauss syndrome: culprit or innocent bystander? Thorax 63(10):847-849
18. Bibby S, Healy B, Steele R, Kumareswaran K, Nelson H, Beasley R (2010) Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database. Thorax 65(2):132-138
19. Nathani N, Little MA, Kunst H, Wilson D, Thickett DR (2008) Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective. Thorax 63(10):883-888
20. Szczeklik W, Sokolowska B, Mastalerz L et al (2010) The influence of leukotriene receptor antagonists treatment on Churg-Strauss syndrome. Przegl Lek 67(7):439-443
21. Chen KR, Sakamoto M, Ikemoto K, Abe R, Shimizu H (2007) Granulomatous arteritis in cutaneous lesions of Churg-Strauss syndrome. J Cutan Pathol 34(4):330-337 (Pubitemid 46466096)
22. Nagashima T, Cao B, Takeuchi N et al (2002) Clinicopathological studies of peripheral neuropathy in Churg-Strauss syndrome. Neuropathology 22(4):299-307 (Pubitemid 36142762)
23. Peen E, Hahn P, Lauwers G, Williams RC Jr, Gleich G, Kephart GM (2000) Churg-Strauss syndrome: localization of eosinophil major basic protein in damaged tissues. Arthritis Rheum 43(8):1897-1900
24. Drage LA, Davis MD, De Castro F et al (2002) Evidence for pathogenic involvementof eosinophils and neutrophilsin Churg-Strauss syndrome. J Am Acad Dermatol 47(2):209-216
25. Schmitt WH, Csernok E, Kobayashi S, Klinkenborg A, Reinhold-Keller E, Gross WL (1998) Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. Arthritis Rheum 41(3):445-452 (Pubitemid 28128769)
26. Hurst S, Chizzolini C, Dayer JM, Olivieri J, Roux-Lombard P (2000) Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitis. Clin Exp Rheumatol 18(6):784-785
27. Tai PC, Holt ME, Denny P, Gibbs AR, Williams BD, Spry CJ (1984) Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. Br Med J Clin Res Ed 289(6442):400-402 (Pubitemid 14010301)
28. Meziane H, Maakel ML, Vachier I, Bousquet J, Chanez P (2001) Sputum eosinophilia in Churg-Strauss syndrome. Respir Med 95(10):799-801 (Pubitemid 33019574)
29. Schnabel A, Csernok E, Braun J, Gross WL (1999) Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome. Thorax 54(9):771-778 (Pubitemid 29401539)
30. Tsukadaira A, Okubo Y, Kitano K et al (1999) Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. Allergy Asthma Proc 20(1):39-44
31. Jakiela B, Szczeklik W, Sokolowska B et al (2009) Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome. Rheumatol (Oxford) 48(10):1202-1207
32. Rothenberg ME, Hogan SP (2006) The eosinophil. Annu Rev Immunol 24:147-174
33. Termeer CC, Simon JC, Schopf E (2001) Low-dose interferon alfa-2b for the treatment of Churg-Strauss syndrome with prominent skin involvement. Arch Dermatol 137(2):136-138 (Pubitemid 32163661)
34. Kurosawa M, Nakagami R, Morioka J et al (2000) Interleukins in Churg-Strauss syndrome. Allergy 55(8):785-787 (Pubitemid 30619503)
35. Shiota Y, Matsumoto H, Kanehisa Y et al (1997) Serum interleukin-5 levels in a case with allergic granulomatous angiitis. Intern Med 36(10):709-711 (Pubitemid 127515261)
36. Pepper RJ, Fabre MA, Pavesio C et al (2008) Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production. Rheumatol (Oxford) 47(7):1104-1105 (Pubitemid 351865947)
37. Jakieła B, Sanak M, Szczeklik W et al (2011) Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome. Clin Exp Rheumatol (in press)
38. Muschen M, Warskulat U, Perniok A et al (1999) Involvement of soluble CD95 in Churg-Strauss syndrome. Am J Pathol 155(3):915-925 (Pubitemid 29426838)
39. Polzer K, Karonitsch T, Neumann T et al (2008) Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activity. Rheumatol (Oxford) 47(6):804-808 (Pubitemid 351796364)
40. Dallos T, Heiland GR, Strehl J et al (2010) CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome. Arthritis Rheum 62(11):3496-3503
41. Zwerina J, Bach C, Martorana D et al (2011) Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study. Rheumatology (Oxford)
42. Hattori N, Ichimura M, Nagamatsu M et al (1999) Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain 122(Pt 3):427-439 (Pubitemid 29110518)
43. Schonermarck U, Csernok E, Trabandt A, Hansen H, Gross WL (2000) Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol 18(4):457-463 (Pubitemid 30616941)
44. Vaglio A, Martorana D, Maggiore U et al (2007) HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum 56(9):3159-3166 (Pubitemid 47502764)
45. Wieczorek S, Hellmich B, Gross WL, Epplen JT (2008) Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et al. Arthritis Rheum 58(1):329-330
46. Guida G, Vallario A, Stella S et al (2008) Clonal CD8+ TCR-Vbeta expanded populations with effector memory phenotype in Churg Strauss syndrome. Clin Immunol 128(1):94-102
47. Kiene M, Csernok E, Muller A, Metzler C, Trabandt A, Gross WL (2001) Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum 44(2):469-473
48. Fujioka A, Yamamoto T, Takasu H et al (1998) The analysis of mRNA expression of cytokines from skin lesions in Churg-Strauss syndrome. J Dermatol 25(3):171-177
49. Hellmich B, Csernok E, Gross WL (2005) Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome. Ann NY Acad Sci 1051:121-131 (Pubitemid 41362739)
50. Terrier B, Bieche I, Maisonobe T et al (2010) Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome. Blood 116(22):4523-4531
51. Wieczorek S, Hellmich B, Arning L et al (2008) Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis. Arthritis Rheum 58(6):1839-1848 (Pubitemid 351847539)
52. Tsurikisawa N, Saito H, Tsuburai T et al (2008) Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma. J Allergy Clin Immunol 122(3):610-616
53. Saito H, Tsurikisawa N, Tsuburai T, Akiyama K (2008) Involvement of regulatory T cells in the pathogenesis of Churg-Strauss syndrome. Int Arch Allergy Immunol 146(Suppl 1):73-76
54. Nogueira E, Hamour S, Sawant D et al (2010) Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 25(7):2209-2217
55. Saito H, Tsurikisawa N, Tsuburai T, Oshikata C, Akiyama K (2009) Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17. Int Arch Allergy Immunol 149(Suppl 1):61-65
56. Cottin V, Khouatra C, Dubost R, Glerant JC, Cordier JF (2009) Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up. Allergy 64(4):589-595
57. Tsurikisawa N, Tsuburai T, Saito H et al (2007) A retrospective study of bronchial hyperresponsiveness in patients with asthma before the onset of Churg-Strauss syndrome. Allergy Asthma Proc 28(3):336-343
58. Sable-Fourtassou R, Cohen P, Mahr A et al (2005) Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143(9):632-638 (Pubitemid 41552527)
59. Szczeklik W, Sokolowska B, Zuk J, Mastalerz L, Szczeklik A, Musial J (2011) The course of asthma in Churg-Strauss syndrome. J Asthma 48(2):183-187
60. Bacciu A, Bacciu S, Mercante G et al (2006) Ear, nose and throat manifestations of Churg-Strauss syndrome. Acta Otolaryngol 126(5):503-509
61. Szczeklik A, Stevenson DD (2003) Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111(5):913-921 (Pubitemid 36570845)
62. Szczeklik A, Musial J, Dyczek A, Bartosik A, Milewski M (1995) Autoimmune vasculitis preceding aspirin-induced asthma. Int Arch Allergy Immunol 106(1):92-94
63. Szczeklik A, Musial J, Pulka G (1997) Autoimmune vasculitis and aortic stenosis in aspirin-induced asthma (AIA). Allergy 52(3):352-354 (Pubitemid 27166243)
64. Szczeklik W, Mastalerz L, Sokolowska B, Sanak M, Nizankowska-Mogilnicka E (2008) Aspirin tolerance and leukotriene biosynthesis in Churg-Strauss syndrome. Allergy 63(7):949-950 (Pubitemid 351832807)
65. Bottero P, Bonini M, Vecchio F et al (2007) The common allergens in the Churg-Strauss syndrome. Allergy 62(11):1288-1294 (Pubitemid 47537511)
66. Chumbley LC, Harrison EG Jr, DeRemee RA (1977) Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 52(8):477-484 (Pubitemid 8161397)
67. Choi YH, Im JG, Han BK, Kim JH, Lee KY, Myoung NH (2000) Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest 117(1):117-124 (Pubitemid 30053629)
68. Kim YK, Lee KS, Chung MP et al (2007) Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings. Eur Radiol 17(12):3157-3165 (Pubitemid 350142341)
69. Silva CI, Muller NL, Fujimoto K, Johkoh T, Ajzen SA, Churg A (2005) Churg-Strauss syndrome: high resolution CT and pathologic findings. J Thorac Imaging 20(2):74-80 (Pubitemid 40563429)
70. Worthy SA, Muller NL, Hansell DM, Flower CD (1998) Churg-Strauss syndrome: the spectrum of pulmonary CT findings in 17 patients. AJR Am J Roentgenol 170(2):297-300 (Pubitemid 28083825)
71. Szczeklik W, Grzanka P, Mastalerz L, Sokolowska B, Musial J (2010) Lung involvement in Churg-Strauss syndrome as related to the activity of the disease. Allergy 65(11):1484-1485
72. Sinico RA, Di Toma L, Maggiore U et al (2005) Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 52(9):2926-2935 (Pubitemid 41369124)
73. Dennert RM, van Paassen P, Schalla S et al (2010) Cardiac involvement in Churg-Strauss syndrome. Arthritis Rheum 62(2):627-634
74. Neumann T, Manger B, Schmid M et al (2009) Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Med (Baltimore) 88(4):236-243
75. Szczeklik W, Miszalski-Jamka T, Mastalerz L et al (2010) Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission. Circ J (in press)
76. Knockaert DC (2007) Cardiac involvement in systemic inflammatory diseases. Eur Heart J 28(15):1797-1804 (Pubitemid 47236654)
77. Hellemans S, Dens J, Knockaert D (1997) Coronary involvement in the Churg-Strauss syndrome. Heart 77(6):576-578 (Pubitemid 27294701)
78. Pagnoux C, Guillevin L (2005) Cardiac involvement in small and medium-sized vessel vasculitides. Lupus 14(9):718-722 (Pubitemid 41413298)
79. Dropinski J, Szczeklik W, Sokolowska B, Celinska-Lowenhoff M, Milewski M, Szczeklik A (2008) Congestive cardiomyopathy and left intraventricular thrombus as a manifestation of Churg-Strauss syndrome. Kardiol Pol 66(7):761-763
80. Szczeklik W, Sokolowska B, Mastalerz L, Miszalski-Jamka T, Musial J (2010) Heart involvement detected by magnetic resonance in a patient with Churg-Strauss syndrome, mimicking severe asthma exacerbation. Allergy 65(8):1063-1064
81. Hunsaker JC 3rd, O'Connor WN, Lie JT (1992) Spontaneous coronary arterial dissection and isolated eosinophilic coronary arteritis: sudden cardiac death in a patient with a limited variant of Churg-Strauss syndrome. Mayo Clin Proc 67(8):761-766
82. Morgan JM, Raposo L, Gibson DG (1989) Cardiac involvement in Churg-Strauss syndrome shown by echocardiography. Br Heart J 62(6):462-466 (Pubitemid 20008416)
83. Pela G, Tirabassi G, Pattoneri P, Pavone L, Garini G, Bruschi G (2006) Cardiac involvement in the Churg-Strauss syndrome. Am J Cardiol 97(10):1519-1524
84. Marmursztejn J, Cohen P, Duboc D et al (2010) Cardiac magnetic resonance imaging in Churg-Strauss-syndrome. Impact of immunosuppressants on outcome assessed in a prospective study on eight patients. Clin Exp Rheumatol 28(1 Suppl 57):8-13
85. Zhang W, Zhou G, Shi Q, Zhang X, Zeng XF, Zhang FC (2009) Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol 27(1 Suppl 52):S65-S69
86. Targonska-Stepniak B, Majdan M, Haberek G, Papuc E, Wnukowska K (2009) Development of Churg-Strauss syndrome with severe multiple mononeuropathy after leukotriene receptor antagonist treatment in one of the monozygotic twins with asthma: case report. Pol Arch Med Wewn 119(11):761-764
87. Cattaneo L, Chierici E, Pavone L et al (2007) Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis. J Neurol Neurosurg Psychiatry 78(10):1119-1123
88. Szczeklik W, Tutaj M, Sokołowska M et al (2011) Impaired cardiovascular autonomic nervous system function in patients with Churg-Strauss syndrome. Scand J Rheumatol (in press)
89. Pagnoux C, Guilpain P, Guillevin L (2007) Churg-Strauss syndrome. Curr Opin Rheumatol 19(1):25-32 (Pubitemid 44885723)
90. Davis MD, Daoud MS, McEvoy MT, Su WP (1997) Cutaneous manifestations of Churg-Strauss syndrome: a clinicopathologic correlation. J Am Acad Dermatol 37(2 Pt 1):199-203 (Pubitemid 27355704)
91. Jennette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337(21):1512-1523 (Pubitemid 27495778)
92. Cottin V, Cordier JF (2003) Churg-Strauss syndrome. Rev Pneumol Clin 59(1):17-24 (Pubitemid 36775400)
93. Cottin V, Cordier JF (1999) Churg-Strauss syndrome. Allergy 54(6):535-551 (Pubitemid 29301809)
94. Guillevin L, Lhote F, Gallais V et al (1995) Gastrointestinal tract involvement in polyarteritis nodosa and Churg-Strauss syndrome. Ann Med Interne (Paris) 146(4):260-267
95. Oka N, Kawasaki T, Matsui M, Shigematsu K, Unuma T, Sugiyama H (2010) Two subtypes of Churg-Strauss syndrome with neuropathy: the roles of eosinophils and ANCA. Mod Rheumatol (in press)
96. Abril A, Calamia KT, Cohen MD (2003) The Churg Strauss syndrome (allergic granulomatous angiitis): review and update. Semin Arthritis Rheum 33(2):106-114 (Pubitemid 37386204)
97. Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Toumelin PL (2011) The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the french vasculitis study group (FVSG) cohort. Med (Baltimore) 90(1):19-27
98. Watts RA, Scott DG (2009) Recent developments in the classification and assessment of vasculitis. Best Pract Res Clin Rheumatol 23(3):429-443
99. Luqmani RA, Bacon PA, Moots RJ et al (1994) Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. QJM 87(11):671-678 (Pubitemid 24334817)
100. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Carruthers DM, Moots R (1998) Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). Br J Rheumatol 37(1):57-63
101. Exley AR, Carruthers DM, Luqmani RA et al (1997) Damage occurs early in systemic vasculitis and is an index of outcome. QJM 90(6):391-399 (Pubitemid 27254195)
102. Gayraud M, Guillevin L, le Toumelin P et al (2001) Long-term follow-up of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 44(3):666-675 (Pubitemid 32234626)
103. Lapraik C, Watts R, Bacon P et al (2007) BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatol (Oxford) 46(10):1615-1616
104. Chen M, Kallenberg CG (2010) ANCA-associated vasculitides - advances in pathogenesis and treatment. Nat Rev Rheumatol 6(11):653-664
105. Ribi C, Cohen P, Pagnoux C et al (2008) Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients. Arthritis Rheum 58(2):586-594 (Pubitemid 351294896)
106. Cohen P, Pagnoux C, Mahr A et al (2007) Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum 57(4):686-693 (Pubitemid 46764061)
107. Metzler C, Schnabel A, Gross WL, Hellmich B (2008) A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome. Clin Exp Rheumatol 26(3 Suppl 49):S35-S40
108. Arbach O, Gross WL, Gause A (2002) Treatment of refractory Churg-Strauss-Syndrome (CSS) by TNF-alpha blockade. Immunobiology 206(5):496-501 (Pubitemid 36192908)